Research output per year
Research output per year
Personal profile
Headline
Assistant Professor
Fingerprint
Dive into the research topics where Goran Bajic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies
Maurer, D. P., Vu, M., Ramos, A. S. F., Dugan, H. L., Khalife, P., Geoghegan, J. C., Walker, L. M., Bajic, G. & Schmidt, A. G., 25 Apr 2025, In: Science advances. 11, 17, eadu9140.Research output: Contribution to journal › Article › peer-review
-
Human naïve B cells recognize prepandemic influenza virus hemagglutinins
Feldman, J., Ramos, A. S. F., Vu, M., Maurer, D. P., Rosado, V. C., Lingwood, D., Bajic, G. & Schmidt, A. G., Jan 2025, In: Science immunology. 10, 103, eado9572.Research output: Contribution to journal › Article › peer-review
-
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis
Fantin, R. F., Clark, J. J., Cohn, H., Jaiswal, D., Bozarth, B., Rao, V., Civljak, A., Lobo, I., Nardulli, J. R., Srivastava, K., Yong, J. S., Andreata-Santos, R., Bushfield, K., Lee, E. S., Singh, G., van Bakel, H., Chen, Y., Cognigni, C., Fitzgerald, D. & Gleason, C. R. & 14 others, , 2025, (Accepted/In press) In: The Lancet Microbe. 101103.Research output: Contribution to journal › Article › peer-review
-
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody
Atanasoff, K. E., Brambilla, L., Adelsberg, D. C., Kowdle, S., Stevens, C. S., Slamanig, S., Hung, C. T., Fu, Y., Lim, R., Tran, L., Allen, R., Sun, W., Duty, J. A., Bajic, G., Lee, B. & Tortorella, D., Jan 2024, In: mBio. 15, 1Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark, J. J., Hoxie, I., Adelsberg, D. C., Sapse, I. A., Andreata-Santos, R., Yong, J. S., Amanat, F., Tcheou, J., Raskin, A., Singh, G., González-Domínguez, I., Edgar, J. E., Bournazos, S., Sun, W., Carreño, J. M., Simon, V., Ellebedy, A. H., Bajic, G. & Krammer, F., 26 Nov 2024, In: Cell Reports. 43, 11, 114922.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations
Press/Media
-
Research Conducted at Icahn School of Medicine at Mount Sinai Has Updated Our Knowledge about COVID-19 (An in Vitro Experimental Pipeline To Characterize the Epitope of a Sars-cov-2 Neutralizing Antibody)
Stevens, C., Lee, B., Bajic, G., Tortorella, D. & Sun, W.
3/01/24
1 item of Media coverage
Press/Media
-
Research from Icahn School of Medicine at Mount Sinai in Influenza Vaccines Provides New Insights (Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses)
Bajic, G., Krammer, F., Palese, P. & Sun, W.
20/06/23
1 item of Media coverage
Press/Media
-
New “Atlas” Charts How Antibodies Attack SARS-CoV-2 Coronavirus Spike Protein Variants
30/07/21
1 item of Media coverage
Press/Media
-
Novel monoclonal antibody could pave way for future COVID-19 treatments and vaccines
12/07/21
1 item of Media coverage
Press/Media